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s u m m a r y 
Objectives: To understand SARS-Co-V-2 infection and transmission in UK nursing homes in order to de- 
velop preventive strategies for protecting the frail elderly residents. 
Methods: An outbreak investigation involving 394 residents and 70 staff, was carried out in 4 nursing 
homes affected by COVID-19 outbreaks in central London. Two point-prevalence surveys were performed 
one week apart where residents underwent SARS-CoV-2 testing and had relevant symptoms documented. 
Asymptomatic staff from three of the four homes were also offered SARS-CoV-2 testing. 
Results: Overall, 26% (95% CI 22–31) of residents died over the two-month period. All-cause mortality 
increased by 203% (95% CI 70–336) compared with previous years. Systematic testing identified 40% (95% 
CI 35–46) of residents as positive for SARS-CoV-2, and of these 43% (95% CI 34–52) were asymptomatic 
and 18% (95% CI 11–24) had only atypical symptoms; 4% (95% CI −1 to 9) of asymptomatic staff also 
tested positive. 
Conclusions: The SARS-CoV-2 outbreak in four UK nursing homes was associated with very high infection 
and mortality rates. Many residents developed either atypical or had no discernible symptoms. A num- 
ber of asymptomatic staff members also tested positive, suggesting a role for regular screening of both 
residents and staff in mitigating future outbreaks. 
© 2020 The Author(s). Published by Elsevier Ltd on behalf of The British Infection Association. 
This is an open access article under the CC BY license. ( http://creativecommons.org/licenses/by/4.0/ ) 
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Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
nfection has affected large numbers of nursing home residents
orldwide. The World Health Organization has estimated that astion Association. This is an open access article under the CC BY license. 
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2many as half of all coronavirus disease 2019 (COVID-19) deaths in
Europe occurred in care homes, and UK Office for National Statis-
tics (ONS) figures confirmed large numbers of deaths in England
and Wales in this setting. 1 2 The true figures are likely to be
even higher when indirect mortality effects of the outbreak are
accounted for. 3 Currently, 416,0 0 0 people live in UK care homes, 4 
and in addition to their advanced age, the presence of multiple
co-morbidities, such as cardiovascular disease and dementia 5 sig-
nificantly increases their risk of severe disease and death due to
SARS-CoV-2. 6 In the UK, 89% of deaths due to SARS-CoV-2 are in
adults aged > 65 years and 43% in those aged > 85 years. 7 Despite
the high rates of morbidity and mortality among care home resi-
dents, little is known about infection, symptomatology and trans-
mission of SARS-CoV-2 in this highly vulnerable care setting 
As with other infections in older people, 8 early reports have
suggested that the clinical manifestations of COVID-19 may be dif-
ficult to recognise because the typical symptoms such as cough
and breathless may already be present due to other comorbidi-
ties, 9 or they may have non-specific and/or atypical presentations.
Despite the use of standard infection control measures, rapid and
widespread transmission of SARS-CoV-2 has been reported because
of high infectivity both in the pre-symptomatic phase of the ill-
ness and a high prevalence of asymptomatic residents in the care
home setting. 10 Within a skilled nursing facility in Washington
State USA, 11 64% of residents tested positive for SARS-CoV2 and
25% of infected residents died. 10 Half of those testing positive were
asymptomatic at the time of testing, and this was felt to be a key
factor contributing to transmission. Traditional approaches to in-
fection control advocated by UK government policy that rely on
identification of symptomatic cases and rapid case-isolation may,
therefore, be ineffective for limiting the spread of SARS-CoV-2 in
care and nursing homes. 
Here we report results from an outbreak investigation affecting
four UK nursing homes with 394 residents. This investigation was
initiated after an unusually high number of residents in one nurs-
ing home became unwell in late March/early April 2020. Many res-
idents did not display the typical SARS-CoV-2 symptoms of fever
and cough, but died after a short period of becoming acutely un-
well. 
Methods 
Outbreak investigation 
On 10 March 2020, when the WHO declared the COVID-19 out-
break a pandemic, there were 373 confirmed cases of COVID-19 in
the UK. On 19 March 2020, a resident of Nursing Home A died fol-
lowing an illness consistent with COVID-19. On 25 March, a new
resident with confirmed COVID-19 was admitted from home. The
first definite de-novo case within Home A was confirmed positive
on 26 March. A total of eighteen new residents were admitted to
Home A from hospital and 26 residents died between early March
and its closure to admissions on 9 April 2020. Because of on-going
infections and deaths, comprehensive swabbing of residents and
staff was started on 15 April using the increased testing capac-
ity that was put in place. Prior to this date, SARS-CoV-2 testing
was being offered for a maximum of five symptomatic residents in
each nursing home to confirm an outbreak. Mass testing was pos-
sible because of deployment of a high-throughput robotic platform
on 10 April, such that local capacity for testing outstripped testing
requirement by local hospitals. 12 
The outbreak investigation was convened by the local author-
ity’s Director of Public Health in collaboration with general prac-
titioners, infectious diseases experts, a geriatric clinical outreach
team and academics to perform point-prevalence surveys at two
time points. Clinical and demographic information was collectedlongside comprehensive swabbing of residents. Test results were
eported back to residents and care staff promptly for cohorting
nd implementing additional infection prevention measures where
eeded. Three phases of testing were performed across the four
ursing homes. The second phase involved swabbing of all pre-
iously untested or test-negative residents. Those who had tested
egative or who were unavailable for testing in the previous round
ere additionally swabbed one week later. 
A convenience sample of asymptomatic staff, chosen to cover
he range of roles staff perform within the nursing homes, was
lso tested to assess infection and potential for transmission. These
oles included health care assistants, registered nurses, kitchen
taff, administrators, domestic and maintenance staff. Staff testing
as conducted in three out of the four homes investigated. Nursing
ome managers were interviewed to establish staff absence rates
efore and during the outbreak. Combined oropharyngeal and na-
opharyngeal testing with a synthetic fibre swab was used for all
he initial tests. The swab was placed into a sterile viral trans-
ort medium in keeping with PHE guidance. 13 Verbal informed
onsent was sought from those individuals with mental capacity.
n residents lacking capacity swabbing was performed in the indi-
idual’s best interests based on clinical judgement. Our procedure
as revised to bilateral anterior nasal swabbing on 29 April in re-
ponse to accumulating evidence suggesting equivalent sensitivity
f this approach and the better acceptability of this less invasive
pproach. 14–16 
SARS-CoV-2 was detected using real-time reverse-transcriptase
olymerase chain reaction (rt-PCR) in a National Health Service
NHS) diagnostic hospital laboratory using validated assays includ-
ng the AusDiagnostics, Roche Cobas and Abbott RealTime SARS-
oV-2 assays. If a sample was inconclusive on initial testing, it was
epeated using a different assay to confirm a positive/negative re-
ult. 
ymptom ascertainment, demographics and comorbidities 
Demographic and comorbidity status was obtained from case
ote review as well as the medical and nursing team. Five key
ymptoms were recorded including typical (new fever, cough
nd/or breathlessness) and atypical (newly altered mental status
r behaviour, anorexia, diarrhoea or vomiting) features of COVID-
9. Retrospective assessment was undertaken for the two weeks
rior to the first systematic round of testing, with reassessment
erformed one week later (mean 6.7 days, SD 2.4) in all those who
ere asymptomatic at the first testing timepoint. 
tatistical analysis 
Data are mainly descriptive. Chi squared test was used to com-
are categorical data and Wilcoxon rank sum test for non-normally
istributed continuous variables. We performed multivariable lo-
istic regression of presenting symptoms in those who had an
vailable test in the initial comprehensive testing round. Analyses
ere performed in R version 3.6.0. 
iral sequencing 
To evaluate genomic diversity of the circulating SARS-CoV-2
trains in the care homes, 19 samples were selected from resi-
ents ( n = 18) and staff ( n = 1) who tested positive for SARS-CoV-
. Genomes were extracted, enriched and sequenced following the
RTIC v3 Illumina protocol (see Supplementary Methods). High
uality paired-end reads were generated on an Illumina MiSeq in-
trument and sequences were assembled against the Wuhan-Hu-1-
019 reference genome (NCBI accession MN908947). 
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Fig. 1. Timeline of COVID-19 outbreak and associated mortality. Panel A – deaths per day throughout the outbreak timeline from 1 March to 1 May 2020 in all four homes, 
with key dates denoted. Colours relate to the presence of COVID-19 on medical certificate of cause of death (MCCD). Homes were closed to visitors on 16 March; a limited 
number of tests were made available for symptomatic testing on 2 April by Public Health England; systematic testing within the outbreak investigation commenced on 15 
April. Panel B – deaths per day in each nursing home separately. Dates of first positive COVID-19 test (T1) and death-certificate coded COVID-19 death (D1) in each home are 
shown. Panel C – cumulative number of deaths of all causes, including non-COVID-19, throughout the two-month period (red). Historic average number of deaths throughout 
the same period in 2018 and 2019 is shown in grey for comparison. 
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S  thical approval and patient and public involvement 
We report the results of an outbreak investigation undertaken
s part of usual public health practice for the purposes of defining
he cause of the outbreak and how best to manage it. As such the
ork did not require Research Ethics Committee approval. This is
n keeping with UK Health Research Authority guidance and was
onfirmed with the chair of the West London and GTAC research
thics committee. Patients / members of the public were not in-
olved in its design. 
esults 
ursing home mortality 
394 nursing home residents were included in the outbreak in-
estigation. All-cause mortality during the period between 1 March
o 1 May 2020 inclusive was 26% (95% CI 22–31, N = 103). The peak
f deaths occurred in the first week of April. A similar time course
as observed across the four nursing homes investigated ( Fig. 1 ),
ith marked increases in death rate in homes A, B and D. Compar-
son with the same time-period in the preceding two years showed 203% (95% CI 70–336) increase in all-cause deaths over the inves-
igation period ( Table 1 ). 
Men had a significantly increased risk of death (48% of deaths
s. 34% in those who survived; whole group 38% male, P = 0.020)
nd there was a trend for the median age to be greater among
hose who died ( P = 0.058) ( Table 2 ). Residents had on average
hree of the co-morbidities assessed ( Table 2 ), with dementia be-
ng the most common (57%) followed by cardiovascular disease
CVD; 51%). Cardiovascular disease was the only co-morbidity sig-
ificantly associated with increased mortality (65% of those who
ied had CVD versus 45% of survivors; P = 0.0010, Fig. 2 (B)). 
The medical certificate of cause of death (MCCD) was reviewed
or 99/103 residents ( Fig. 1 , panel A). The death certificates listed
onfirmed or suspected COVID-19 as the underlying cause in the
ajority of cases ( n = 53, 54%, 95% CI 44 to 63). The 46 deaths
hat were coded on the certificate as non-COVID happened ear-
ier in the outbreak on average (mean days since March 1st 33.0,
D 14.2) compared to documented covid-19 deaths (mean 39.1,
D 14.2; W = 1544, P = 0.023). Twelve of these 46 ‘non-covid-19 ′ 
eaths were attributed to pneumonia or lower respiratory tract in-
ections and of these three had been tested and were negative for
ARS-CoV-2. Sixteen were attributed to frailty or old age, interact-
414 N.S.N. Graham, C. Junghans and R. Downes et al. / Journal of Infection 81 (2020) 411–419 
Table 1 
Nursing home information at baseline and during outbreak. First COVID-19 death refers to first death where this is either suspected or confirmed on death certificate. Death 
rates are calculated for the study period of March and April each year. Increase in death rate in 2020 (%) is calculated for each home by subtracting the average 2018–2019 
from the 2020 figure, then dividing by the average 2018–2019 death rate and multiplying by 100. 
Summary Home A Home B Home C Home D 
mean (SD) 
Nursing home caseload 
N Beds 98.5 (33.8) – – – –
bedbound (%) 36.9 (21.9) 68.0 27.0 35.0 17.5 
Time-course 
First rt-PCR confirmed case – 26 March 28 March 16 April 30 March 
First COVID-19 death – 19 March 28 March 18 April 26 March 
Closure to new admissions – 9 April 8 April 20 April 31 March 
Comprehensive testing begins – 15 April 24 April 23 April 22 April 
Re-testing of negative residents – 29 April 1 May 30 April 30 April 
Deaths per 100 beds per month 
2018 – 5.1 5.3 7.8 6.0 
2019 – 3.4 2.3 8.3 2.2 
2020 – 12.5 15.7 9.3 16.0 
Increase in 2020,% 203.3 (136.2) 191.2 313.2 15.4 293.5 
Table 2 
Associations of mortality in nursing homes during COVID-19 outbreak. 
All Survived Died P Statistic 
N % N % N % 
Demographics 
Residents encountered 394 – 291 73.9 103 26.1 – – –
Male 148 37.6 99 34.0 49 47.6 0.020 χ 2 5.3 
Age, median (IQR) 83 (15) – 82 (15.5) – 84 (13.5) – 0.058 W 16871.0 
Ethnicity 
Black and minority ethnic 73 18.5 56 19.2 17 16.5 0.080 χ 2 5.2 
White 297 75.4 222 76.3 75 72.8 – – –
Unknown 24 6.1 13 4.5 11 10.7 – – –
Comorbidities 
N residents with: 
Diabetes 92 23.4 71 24.4 21 20.4 0.48 χ 2 0.5 
Cardiovascular disease 199 50.5 132 45.4 67 65.0 0.0010 χ 2 10.8 
Chronic kidney disease 86 21.8 65 22.3 21 20.4 0.77 χ 2 0.1 
Stroke 95 24.1 73 25.1 22 21.4 0.55 χ 2 0.4 
Dementia 223 56.6 160 55.0 63 61.2 0.35 χ 2 0.9 
Lung disease 59 15.0 41 14.1 18 17.5 0.51 χ 2 0.4 
N comorbidities: 
Mean (SD) 2.91 (1.11) – 2.87 (1.14) – 3.06 (1.02) – 0.1273 W 16445.0 
Fig. 2. COVID-19 Symptoms, Outcomes and Comorbidities. (A) Relationship of COVID-19 symptoms in two weeks preceding swabbing with SARS-CoV-2 test result. ‘Confusion’ 
refers to altered mental status or behaviour. GI symptoms refers to diarrhoea and/or vomiting. (B) Relationship of comorbidities to all-cause mortality; CVD: cardiovascular 
disease; CKD: chronic kidney disease; lung disease refers to chronic lung disease. 
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Table 3 
Clinical symptoms and SARS-CoV-2 rt-PCR test status. 
Any result Negative Positive P Statistic 
N % N % N % 
Residents tested 313 – 187 59.7 126 40.3 – – –
Deaths 29 – 8 4.3 21 16.7 0.0004 χ2 12.3 
Symptom information 
Symptomatic 109 34.8 37 19.8 72 57.1 < 0.0001 χ2 44.7 
Asymptomatic 204 65.2 150 80.2 54 42.9 – – –
N symptoms, mean (SD) 0.7 (1.1) – 0.3 (0.7) – 1.2 (1.3) – < 0.0001 W 16542.0 
Any typical symptom 73 23.3 23 12.3 50 39.7 < 0.0001 χ2 30.1 
Any atypical symptom 73 23.3 22 11.8 51 40.5 < 0.0001 χ2 33.1 
Typical symptoms only 35 11.2 14 7.5 21 16.7 0.019 χ2 5.5 
Atypical symptoms only 35 11.2 13 7.0 22 17.5 0.0067 χ2 7.3 
Typical symptoms 
Cough/Breathlessness 57 18.2 16 8.6 41 32.5 < 0.0001 χ2 27.5 
Fever 43 13.7 13 7.0 30 23.8 < 0.0001 χ2 16.7 
Atypical symptoms 
Confusion/Altered behaviour 62 19.8 19 10.2 43 34.1 < 0.0001 χ2 25.7 
Anorexia 44 14.1 10 5.3 34 27.0 < 0.0001 χ2 27.4 
Diarrhoea/Vomiting 4 1.3 2 1.1 2 1.6 1.0 χ2 0.0 
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h  ng with other comorbidities such as dementia. Two of these resi-
ents were rt-PCR positive. In the four individuals where the MCCD
as unavailable, the SARS-CoV-2 rt-PCR test was positive and the
P considered the death likely due to COVID-19. 
ARS-CoV-2 testing results and clinical features 
A comprehensive SARS-CoV-2 testing programme for residents
as initiated on 15 April 2020. 313 residents were tested in total
 Table 3 ). Fewer than 20 residents declined or were unavailable for
esting. Of those tested, 126 (40%, 95% CI 35 to 46) of the residents
ere positive for SARS-CoV-2. As of 1 May 2020, 21 (17%, 95% CI
0–23) residents who tested positive and 8 (4%, 95% CI 1–7) with
egative tests had died ( P = 0.0 0 04). 
Residents with negative rt-PCR results who were available for
epeat swabbing around 1 week after the initial test, were re-
ested ( n = 173). Combined nasopharyngeal oropharyngeal swab-
ing was used at the first testing point, whereas anterior nasal
wabbing was used for repeat testing. Of these, five (3%, 95% CI
–5) tested positive for SARS-CoV-2 at the second time point. 
We assessed the diagnostic value of typical and other COVID-
9 symptoms in nursing home residents. 23 (12%, 95% CI 8–17) of
hose who tested negative had displayed one or more of the typical
OVID-19 symptoms of cough or fever in the previous two weeks
 Table 3 ). Of 126 (40%) residents who tested positive, well over a
hird had no symptoms ( n = 54, 43%, 95% CI 34–52). Out of the 72
57%, 95% CI 49–66) residents who did exhibit symptoms, 50 (70%
f symptomatic, 95% CI 59–80) had any typical symptoms of fever
r cough / breathlessness. As many as 22 (31%, 95% CI 20–41) of
hose who were symptomatic with SARS-CoV-2 had none of the
ypical symptoms. 
In our group of residents, the symptom with the strongest inde-
endent association with a positive test result for SARS-CoV-2 was
ew onset anorexia ( Figs. 2 (A), and 3 ). Regardless of other symp-
oms, a resident with new onset anorexia was almost four-times
ore likely to have SARS-CoV-2 infection than an individual who
id not (OR 3.74, 95% CI 1.5–9.8). The only other symptoms sig-
ificantly and independently associated with a positive test result
as having either/or cough and shortness of breath (OR 3.72, 95%
I 1.8–7.8). Fever was not independently associated with a positive
est, neither was altered mental state/behaviour or diarrhoea. taff sickness and asymptomatic viral carriage 
596 members of staff were employed in a variety of roles across
he four nursing homes with additional support or illness-cover
rom agency workers (mean n = 149 per home). Staff absence rates
ue to sickness/self-isolation during the period 1 March to 1 May
020 were markedly elevated at more than three times the back-
round level (215.9% increase, 95% CI 80 to 352). 70 asymptomatic
taff members were tested across three nursing homes (A, C, D).
taff were selected to ensure representation from different roles
ithin the homes. Three (16%, 95% CI −1 to 32) of the 19 staff
ested in Home A were positive for SARS-CoV-2; no staff tested
ositive in Homes C or D (total 4%, 95% CI −1 to 9). Nasopharyn-
eal/oropharyngeal swabbing was performed in Home A. Anterior
asal swabbing was performed in Homes C and D ( Table 4 ). 
ARS-CoV-2 sequencing 
Consensus genomes for 19 positive sample were compared be-
ween different residents and different care homes and a Max-
mum Likelihood phylogenetic tree was calculated ( Fig. 4 ). Se-
uences were analysed in the context of 400 SARS-CoV-2 se-
uences from around the UK (see Supplementary Fig. 1). Some
ARS-CoV-2 sequence variants were highly similar between resi-
ents and/or staff within a single care home. However, this data
lso showed multiple distinct clusters of SARS-CoV-2 sequence
ypes within single nursing homes. 
iscussion 
An investigation of COVID-19 outbreaks across four nursing
omes in central London identified 103 (26%) fatalities among resi-
ents over the two-month period spanning the peak of the London
OVID-19 epidemic. These deaths represented a more than two-
old increase compared to the same period in the two previous
ears, with the increase mostly attributable to three of the four
omes investigated. COVID-19 was listed as causative or contribu-
ory on just over half of death certificates and was likely under-
eported in the context of limited testing and non-specific symp-
oms. Twenty-seven days after the first death and 21 days after
he first resident tested positive, we found 126 (40%) of nursing
ome residents were SARS-CoV-2 positive and 54 (43%) positive
416 N.S.N. Graham, C. Junghans and R. Downes et al. / Journal of Infection 81 (2020) 411–419 
Fig. 3. Association of symptoms with a positive SARS-CoV-2 rt-PCR result. Relationship of symptom in preceding two weeks to a positive SARS-CoV-2 result in all residents 
tested ( n = 313), displayed as adjusted odds ratios with 95% confidence intervals. Significant predictors in model indicated by ∗∗ P < 0.01; ∗∗∗ P < 0.001. 
Table 4 
Nursing home staffing, infection rates and absences. 
Summary Home A Home B Home C Home D 
mean (SD) 
Sick or isolating per month 
Baseline, N (%) – – 4.0 (5.1%) 8.5 (5.7%) 8.0 (6.7%) 
Average Mar/Apr 2020, N (%) – – 17.5 (22.1%) 16.8 (11.2%) 25.0 (21.0%) 
Increase in sick/isolating rate (%) 215.9 (120.0) – 337.5 97.6 212.5 
Asymptomatic testing 
Date(s) of testing – April 25 – 29 April, 1 May 1 May 
Tested, N (% all staff) 15.6 (11.8%) 19 (7.6%) – 44 (29.3%) 7 (8.8%) 
Positive, N (% tested) 3.0 (4.3%) 3 (15.7%) – 0 (0.0%) 0 (0.0%) 
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a  residents were asymptomatic. Three of 70 asymptomatic staff (4%)
representing various roles in the care home were also positive for
SARS-CoV-2. These data catalogue the widespread transmission of
SARS-CoV-2 through four UK nursing homes associated with high
case fatality rates during the peak pandemic period. 
A striking finding of our investigation was that 60% of SARS-
CoV-2 positive residents were either asymptomatic or only had
atypical symptoms for COVID-19 during the two weeks prior to
testing. This was also true of many residents in the days leading
up to death indicating that even in severe COVID-19, fever and
cough were commonly absent. A novel finding was the strong as-
sociation between anorexia SARS-CoV-2 positivity in addition to
cough/breathlessness. For influenza, atypical symptoms and signs
in the elderly and frail are well-recognised, and this is acknowl-
edged in the national guidelines for ‘flu outbreak management. 17 
The initial national drive using symptom-based criteria of fever
and cough for testing and isolating individuals may, therefore, have
contributed to delays in instituting appropriate infection control
measures and, in the nursing home setting, contributed to the
large numbers of deaths observed in this highly vulnerable pop-
ulation. 
Of the 49 positive residents who were asymptomatic at first
testing, only five (10%) went on to develop symptoms. This is in
marked contrast to the 89% pre-symptomatic residents identified
in the US care home study. 10 Our first survey occurred later in the
outbreak compared to the US study, which may explain the dif-
fering pre-symptomatic rates: 21 vs 10 days after the first positive
test, and 27 after the first COVID-attributed death. A proportion
of our 44 “asymptomatic” residents may have in fact been “post-
symptomatic”, with possible symptoms before the two week ascer-
tainment window and unusually prolonged rt-PCR positivity. How-
ever, a significant number of the residents are likely to have had
true asymptomatic SARS-CoV-2 infection. 18–21 Serological investi-
gation may help clarify this issue in the future. We also identified asymptomatic nursing home staff as poten-
ial source of viral transmission to the residents. Despite a large
roportion of staff self-isolating because they were either unwell
r contacts of the confirmed case during the pandemic period, 4%
f the working staff who were asymptomatic at the time tested
ositive for SARS-CoV-2. Additionally, genomic analysis identified
ne cluster involving one staff member and two residents in the
ame home. Testing asymptomatic staff members has not been re-
orted in previous studies. This group is likely to have been an im-
ortant route for SARS-CoV-2 transmission into and within nurs-
ng homes. Viral sequencing provided evidence for multiple viral
trains within a single nursing home, suggesting that there were
ultiple introductions into individual nursing homes. 
The strengths of this surveillance lie in the large numbers of
esidents tested across four care homes and over time, with rapid
eporting of results and genome sequencing of SARS-CoV-2 isolates
o inform transmission patterns. This investigation had some lim-
tations. Firstly, the non-specific nature of COVID-19 symptoms in
esidents and the lack of availability of tests meant that COVID-19
ad to be inferred as the cause of excess deaths in nursing homes
rior to our investigation. Since symptoms are often difficult to
licit in residents and are not reliably documented in the records,
ymptom ascertainment for the 14 days prior to testing was likely
o be incomplete. However, we made use of several sources includ-
ng the residents, care home workers, GPs and records and believe
hat our data provide a real-life picture. We are only able to infer
he role of asymptomatic care staff as potential sources of trans-
ission based on first, staff self-isolation and sickness levels, sec-
nd, the fact that bedbound residents did not leave the nursing
omes and third, similarities in genome sequences of SARS-CoV-2
trains between staff and residents. We could not infer direction
f transmission between the two however. A wider exploration of
he role of staff was limited by lack of data including reasons for
bsences, resource issues and lack of compensation for staff mem-
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Fig. 4. SARS-CoV-2 variants in nursing homes. Maximum likelihood phylogenetic tree showing SARS-CoV-2 sequence variation across and within the four nursing homes, in 
the UK context, by date of sample result. The Wuhan-Hu-1 2019 reference strain is shown to the far left. Coloured dots represent the sequences originating from residents 
(n = 18) and staff (n = 1, see asterisk), alongside 400 publicly shared sequences from England, Wales, Scotland and Northern Ireland (in grey, see supplementary). Phylogenetic 
analysis and figure obtained using Nextstrain. 
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mers who were aware that if they were SARS-CoV-2 positive, they
ould have to self-isolate and potentially lose significant income. 
Our findings highlight the challenges of controlling SARS-CoV-
 outbreaks in nursing homes. Given the very high mortality ob-
erved in the care homes we investigated, this is a pressing is-
ue. During the course of our outbreak investigation, public health
olicy evolved as the impact of COVID-19 in nursing homes be-
ame apparent. At the time of writing, access to testing for all
esidents and staff has been recommended. 22 Our results support
he need for a policy of universal and systematic testing coupled
ith a high level of surveillance to ensure the policy is imple-
ented effectively. A regime that involves repeated testing is re-
uired because of the potential for asymptomatic residents being
nfected with SARS-CoV-2 within one week, as we have demon-
trated. 14 Regular testing would enable positive residents and staff
o be rapidly identified and appropriate control measures imple-
ented in a timely fashion. 
There are, however, practical challenges with more systematic
esting of residents and staff in nursing homes. These include logis-
ical barriers to the organisation of mass swabbing and the timely
esponse to results. Nursing homes and linked medical teams will
equire additional resources to overcome these barriers. Staff test-
ng adds additional challenges including concerns about the impact
f staff self-isolation on the ability of a nursing home to continueperating, staff concerns about loss of pay due to self-isolation if
ositive, and logistical issues such as the need to test temporary
taff before allowing them to work in the nursing home. 
Research is urgently needed to clarify some key issues to inform
nfection control guidelines. For example, it is currently unclear
ow frequently testing should be performed. Longitudinal stud-
es with linked serological assessment are also needed. The most
ppropriate level of personal protective equipment (PPE) for staff
orking in nursing homes is still unclear. Basic equipment such
s plastic aprons may be inadequate given the close contact often
equired for bed-bound residents. In addition, it is unclear how
est to respond to a positive SARS-CoV-2 test in a nursing home
ontext. There are a range of possible options including cohort-
ng positive residents, restricting seronegative staff from caring for
ositive residents, enhancing PPE usage during outbreaks and clos-
ng the home to visitors and unnecessary personnel earlier dur-
ng an outbreak. Practical measures to minimise the risk of spread
ithin and between visitors, staff and residents need to be evalu-
ted in a formal and systematic manner. These will need to negoti-
te the challenges of infection control in nursing homes, including
he presence of communal living areas, the wandering behaviours
f some residents with dementia, and the constraints of the living
nvironment where decontaminating carpets and soft furnishings
ay be difficult, and where residents may not easily move rooms. 
418 N.S.N. Graham, C. Junghans and R. Downes et al. / Journal of Infection 81 (2020) 411–419 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
U  
(  
t  
g
R
 
s  
w
T
 
r  
t  
a  
e
S
 
f
R
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 High mortality rates for nursing homes affected by SARS-CoV-2
necessitate new approaches to infection control. We have shown
that the reliance on typical symptoms of COVID-19 infection is in-
adequate. More comprehensive and regular testing for SARS-CoV-2
is needed at the outset to identify asymptomatic staff and resi-
dents, as well as those with atypical symptoms. Further research
is needed to inform the most effective and practicable infection
control measures to be implemented in an agile way before and
during future nursing home outbreaks. 
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